Search results for: "Novo Nordisk" (283 records) Research & Development Oligonucleotides cleavage breakthrough with Vapourtec system Scientists at Novo Nordisk in Denmark have applied flow chemistry to enhance the cleavage of oligonucleotides. Manufacturing Flow photochemistry enables peptide breakthrough Vapourtec R-Series and UV-150 photochemical reactor are used by scientists at Novo Nordisk for functionalisation of peptides and proteins Research & Development Glox Therapeutics appoints Dr Michael Murray as Chair and Dr Nel Moore to its SAB As Chair of the Board, Dr Michael Murray will work with the team to accelerate the company’s growth, while Dr Moore will join the scientific advisory board to support the... Finance Weight loss drugs boost big pharma earnings, says AvaTrade This week pharmaceutical giants Eli Lilly and Novo Nordisk both released their financial results for the fourth quarter of 2024, showcasing major developments in their obesity... Finance Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark Manufacturing Novo Nordisk invests DKK 8.5bn into new Danish modular production site This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within... Manufacturing Novavax sells protein manufacturing facility to Novo Nordisk for $200m Novo Nordisk's purchase of Novavax's Czech recombinant protein manufacturing facility will involve a full transfer of assets — including its workforce and associated support... Manufacturing Novo Nordisk acquires license to Ascendis Pharma's TransCon tech for up to $286m Novo Nordisk will use the technology to develop, manufacture and commercialise therapeutics for metabolic and cardiovascular diseases Regulatory Novo Nordisk's haemophilia A/B drug Alhemo gets positive opinion from the EMA The subcutaneous, self-administering prophylactic can allow a patient to produce thrombin, a clotting agent, even in the presence of inhibitors Digital AI in pharma: the trends and future of the tech in the industry AI can enhance the efficiency and cost-effectiveness of a range of processes across the pharmaceutical industry, so S&P Global explores the current scope of the tech and its... Ingredients The promising future of GLP-1s and oral peptides Dr Andy Lewis, Chief Scientific Officer at Quotient Sciences, examines the trends driving the adoption of oral peptide products and discusses strategies to overcome the... Lonza appoints Juan Andres and Eric Drapé to its Board as independent members The two bring a wealth of pharmaceutical knowledge, and have worked in a number of leadership positions at pharma giants such as Novo Nordisk, Moderna and Eli Lilly Regulatory Novo Nordisk's Wegovy gains positive opinion from the EMA for cardiovascular event risk reduction The GLP-1 medication has proven effective at reducing the risk of major adverse cardiovascular events in adults with established cardiovascular disease Manufacturing Novo Nordisk teams up with Bio Farma and Indonesian government to enhance national diabetes drug accessibility The collaboration will aim to enhance the availability of insulin and other diabetes drug products in Indonesia, where diabetes is one of the top three killers annually Pharmaceutical Pharma giants Roche and Novartis top worldwide reputation poll The report examined the reputations of the 34 biggest pharmaceutical companies globally, including GSK, Novartis, Pfizer, Moderna and Johnson & Johnson Sustainability A greener future: how can the pharmaceutical manufacturing industry meet rapidly shifting ESG targets? The results of a CPHI Annual Survey have shown that sustainability will be a key focus for the pharmaceutical industry in the next few years as goals and metrics are... Previous123 (current)4567…18Next